Effect of MM-141 on gemcitabine and nab-paclitaxel potentiation in preclinical models of pancreatic cancer through induction of IGF-1R and ErbB3 degradation.
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Emily Pace, Sharlene Adams, Adam Camblin, Michael Curley, Victoria Rimkunas, Lin Nie, Sergio Iadevaia, Gege Tan, Jason Baum, Akos Gabor Czibere, Alexey Lugovskoy
Institution: Merrimack Pharmaceuticals (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1829323300